Results 341 to 350 of about 3,462,732 (382)

Thrombotic microangiopathies and antineoplastic agents.

Néphrologie & Thérapeutique, 2017
S. Grangé, P. Coppo
semanticscholar   +1 more source

2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents

Supportive Care in Cancer, 2016
K. Jordan, A. Chan, R. Gralla, Franziska Jahn, B. Rapoport, D. Warr, P. Hesketh   +6 more
semanticscholar   +1 more source

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly  

Chapter 57 – Pharmacology and Molecular Mechanisms of Antineoplastic Agents for Hematologic Malignancies

, 2017
S. Gerson, P. Caimi, B. William, R. Creger   +3 more
semanticscholar   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly  

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

An update on larynx cancer

Ca-A Cancer Journal for Clinicians, 2017
Kristin A Higgins, Nabil F Saba
exaly  

Nanooncology: The future of cancer diagnosis and therapy

Ca-A Cancer Journal for Clinicians, 2013
Sanjiv S Gambhir
exaly